Degradation of troponin i in serum or plasma: Mechanisms, and analytical and clinical implications

Seminars in Thrombosis and Hemostasis

Volumn 38, Issue 2, 2012, Pages 222-229

  Lippi, Giuseppe ^a   Cervellin, Gianfranco ^b  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY HOSPITAL OF PARMA   (Italy)

Author keywords

degradation; interference; preanalytical variability; proteolysis; troponin

Indexed keywords

CALPAIN; CASPASE; CATHEPSIN L; EPITOPE; TROPONIN I;

ACUTE CORONARY SYNDROME; ARTICLE; ENZYMATIC DEGRADATION; HUMAN; IMMUNOASSAY; IMMUNOREACTIVITY; MEASUREMENT; NONHUMAN; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN MODIFICATION;

BIOLOGICAL MARKERS; CALPAIN; CATHEPSIN L; CHEST PAIN; EPITOPE MAPPING; EPITOPES; HUMANS; IMMUNOASSAY; LEUKOCYTES; METALLOPROTEASES; MYOCARDIAL INFARCTION; MYOCARDIUM; PROTEIN PROCESSING, POST-TRANSLATIONAL; TROPONIN I;

EID: 84858133049     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0032-1301419     Document Type: Article

References (66)

1. Mair J. Tissue release of cardiac markers: from physiology to clinical applications. Clin Chem Lab Med: 1999; 37 11-12 1077 1084
2. Franchini M, Lippi G, Favaloro EJ. Coagulopathies and thrombosis: usual and unusual causes and associations, part I. Semin Thromb Hemost: 2009; 35 3 257 259
3. Lippi G, Franchini M, Favaloro EJ. Coagulopathies and thrombosis: usual and unusual causes and associations, part II. Semin Thromb Hemost: 2009; 35 7 591 595
4. Favaloro EJ, Lippi G, Franchini M. Coagulopathies and thrombosis: usual and unusual causes and associations, part III. Semin Thromb Hemost: 2010; 36 1 1 5
5. Lippi G, Favaloro EJ, Franchini M. Coagulopathies and thrombosis: usual and unusual causes and associations, part IV. Semin Thromb Hemost: 2011; 37 3 175 180
6. Lippi G, Franchini M. Pathogenesis of venous thromboembolism: when the cup runneth over. Semin Thromb Hemost: 2008; 34 8 747 761
7. Lippi G, Franchini M, Favaloro EJ. Unsuspected triggers of venous thromboembolismtrivial or not so trivial? Semin Thromb Hemost: 2009; 35 7 597 604
8. Gawaz M, Favaloro EJ. Platelets, inflammation and cardiovascular diseases. New concepts and therapeutic implications. Semin Thromb Hemost: 2010; 36 2 129 130
9. Amabile N, Rautou PE, Tedgui A, Boulanger CM. Microparticles: key protagonists in cardiovascular disorders. Semin Thromb Hemost: 2010; 36 8 907 916
10. Lippi G, Franchini M, Targher G. Arterial thrombus formation in cardiovascular disease. Nat Rev Cardiol: 2011; 8 9 502 512
11. Thygesen K, Alpert JS, White HD.; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. J Am Coll Cardiol: 2007; 50 22 2173 2195 (Pubitemid 350123680)
12. Montagnana M, Lippi G, Guidi GC. [New perspectives in the diagnostic approach to acute coronary syndrome]. Recenti Prog Med: 2005; 96 4 171 177
13. Lippi G, Montagnana M, Salvagno GL, Guidi GC. Potential value for new diagnostic markers in the early recognition of acute coronary syndromes. CJEM: 2006; 8 1 27 31
14. Lippi G, Favaloro EJ, Montagnana M, Franchini M. C-reactive protein and venous thromboembolism: causal or casual association? Clin Chem Lab Med: 2010; 48 12 1693 1701
15. Lippi G, Filippozzi L, Montagnana M, Salvagno GL, Guidi GC. Diagnostic value of D-dimer measurement in patients referred to the emergency department with suspected myocardial ischemia. J Thromb Thrombolysis: 2008; 25 3 247 250 (Pubitemid 351772726)
16. Lippi G, Montagnana M, Guidi GC. Albumin cobalt binding and ischemia modified albumin generation: an endogenous response to ischemia? Int J Cardiol: 2006; 108 3 410 411 (Pubitemid 43339816)
17. Lippi G, Targher G, Franchini M, Plebani M. Genetic and biochemical heterogeneity of cardiac troponins: clinical and laboratory implications. Clin Chem Lab Med: 2009; 47 10 1183 1194
18. Benamer H, Steg PG, Benessiano J., et al. Comparison of the prognostic value of C-reactive protein and troponin I in patients with unstable angina pectoris. Am J Cardiol: 1998; 82 7 845 850 (Pubitemid 28467357)
19. Adams JE III, Schechtman KB, Landt Y, Ladenson JH, Jaffe AS. Comparable detection of acute myocardial infarction by creatine kinase MB isoenzyme and cardiac troponin I. Clin Chem: 1994; 40 7 Pt 1 1291 1295 (Pubitemid 24205946)
20. Giannoni A, Giovannini S, Clerico A. Measurement of circulating concentrations of cardiac troponin I and T in healthy subjects: a tool for monitoring myocardial tissue renewal? Clin Chem Lab Med: 2009; 47 10 1167 1177
21. Lippi G, Banfi G. Exercise-related increase of cardiac troponin release in sports: An apparent paradox finally elucidated? Clin Chim Acta: 2010; 411 7-8 610 611
22. Lippi G, Montagnana M, Aloe R, Cervellin G. Highly sensitive troponin immunoassays: navigating between the Scylla and Charybdis. Adv Clin Chem;in press
23. Plebani M, Zaninotto M. Cardiac troponins: what we knew, what we know - where are we now? Clin Chem Lab Med: 2009; 47 10 1165 1166
24. Wu AH, Feng YJ, Moore R., et al. Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I. American Association for Clinical Chemistry Subcommittee on cTnI Standardization. Clin Chem: 1998; 44 6 Pt 1 1198 1208 (Pubitemid 28283057)
25. Morjana NA. Degradation of human cardiac troponin I after myocardial infarction. Biotechnol Appl Biochem: 1998; 28 Pt 2 105 111 (Pubitemid 28470094)
26. Labugger R, Organ L, Collier C, Atar D, Van Eyk JE. Extensive troponin I and T modification detected in serum from patients with acute myocardial infarction. Circulation: 2000; 102 11 1221 1226
27. McDonough JL, Arrell DK, Van Eyk JE. Troponin I degradation and covalent complex formation accompanies myocardial ischemia/reperfusion injury. Circ Res: 1999; 84 1 9 20 (Pubitemid 29074876)
28. Feng J, Schaus BJ, Fallavollita JA, Lee TC, Canty JM Jr. Preload induces troponin I degradation independently of myocardial ischemia. Circulation: 2001; 103 16 2035 2037 (Pubitemid 32373003)
29. McDonough JL, Labugger R, Pickett W., et al. Cardiac troponin I is modified in the myocardium of bypass patients. Circulation: 2001; 103 1 58 64 (Pubitemid 32050436)
30. Madsen LH, Christensen G, Lund T., et al. Time course of degradation of cardiac troponin I in patients with acute ST-elevation myocardial infarction: the ASSENT-2 troponin substudy. Circ Res: 2006; 99 10 1141 1147 (Pubitemid 44729939)
31. Labugger R, Organ L, Collier C, Atar D, Van Eyk JE. Extensive troponin I and T modification detected in serum from patients with acute myocardial infarction. Circulation: 2000; 102 11 1221 1226
32. Guiheneuf R, Vuillaume I, Mangalaboyi J., et al. Pneumatic transport is critical for leukaemic patients with major leukocytosis: what precautions to measure lactate dehydrogenase, potassium and aspartate aminotransferase? Ann Clin Biochem: 2010; 47 Pt 1 94 96
33. Lippi G, Favaloro EJ, Franchini M. Laboratory diagnostics and therapy in thrombosis and hemostasis: from bedside to bench to bedside. Semin Thromb Hemost: 2009; 35 1 3 8
34. Lippi G, Chance JJ, Church S., et al. Preanalytical quality improvement: from dream to reality. Clin Chem Lab Med: 2011; 49 7 1113 1126
35. Lippi G, Guidi GC, Mattiuzzi C, Plebani M. Preanalytical variability: the dark side of the moon in laboratory testing. Clin Chem Lab Med: 2006; 44 4 358 365
36. Favaloro EJ, Lippi G, Adcock DM. Preanalytical and postanalytical variables: the leading causes of diagnostic error in hemostasis? Semin Thromb Hemost: 2008; 34 7 612 634
37. Lippi G, Blanckaert N, Bonini P., et al. Haemolysis: an overview of the leading cause of unsuitable specimens in clinical laboratories. Clin Chem Lab Med: 2008; 46 6 764 772 (Pubitemid 351821645)
38. Katrukha AG, Bereznikova AV, Filatov VL., et al. Degradation of cardiac troponin I: implication for reliable immunodetection. Clin Chem: 1998; 44 12 2433 2440 (Pubitemid 28565654)
39. Spitznagel JK, Dalldorf FG, Leffell MS., et al. Character of azurophil and specific granules purified from human polymorphonuclear leukocytes. Lab Invest: 1974; 30 6 774 785
40. Prabhu SD. Cytokine-induced modulation of cardiac function. Circ Res: 2004; 95 12 1140 1153 (Pubitemid 39648205)
41. Legendre JL, Jones HP. Purification and characterization of calpain from human polymorphonuclear leukocytes. Inflammation: 1988; 12 1 51 65 (Pubitemid 18065890)
42. Di Lisa F, De Tullio R, Salamino F., et al. Specific degradation of troponin T and I by -calpain and its modulation by substrate phosphorylation. Biochem J: 1995; 308 Pt 1 57 61
43. Xu PT, Song Z, Li Q, Zhang L, Wang YY, Yu ZB. [Calpain mediates cardiac troponin I degradation in tail-suspended rats]. Sheng Li Xue Bao: 2010; 62 5 415 420
44. Gao WD, Atar D, Liu Y, Perez NG, Murphy AM, Marban E. Role of troponin I proteolysis in the pathogenesis of stunned myocardium. Circ Res: 1997; 80 3 393 399 (Pubitemid 27093354)
45. Ke L, Qi XY, Dijkhuis AJ., et al. Calpain mediates cardiac troponin degradation and contractile dysfunction in atrial fibrillation. J Mol Cell Cardiol: 2008; 45 5 685 693
46. Bando Y, Kominami E, Katunuma N. Purification and tissue distribution of rat cathepsin L. J Biochem: 1986; 100 1 35 42
47. Ogata H, Aranishi F, Hara K, Osatomi K, Ishihara T. Proteolytic degradation of myofibrillar components by carp cathepsin L. J Sci Food Agric: 1998; 76 499 504 (Pubitemid 28202676)
48. Fadeel B, Ahlin A, Henter JI, Orrenius S, Hampton MB. Involvement of caspases in neutrophil apoptosis: regulation by reactive oxygen species. Blood: 1998; 92 12 4808 4818 (Pubitemid 29005884)
49. Saido TC, Sorimachi H, Suzuki K. Calpain: new perspectives in molecular diversity and physiological-pathological involvement. FASEB J: 1994; 8 11 814 822
50. Tschesche H. Human neutrophil collagenase. Methods Enzymol: 1995; 248 431 449
51. Van den Steen PE, Dubois B, Nelissen I, Rudd PM, Dwek RA, Opdenakker G. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit Rev Biochem Mol Biol: 2002; 37 6 375 536 (Pubitemid 36071972)
52. Rouet-Benzineb P, Buhler JM, Dreyfus P., et al. Altered balance between matrix gelatinases (MMP-2 and MMP-9) and their tissue inhibitors in human dilated cardiomyopathy: potential role of MMP-9 in myosin-heavy chain degradation. Eur J Heart Fail: 1999; 1 4 337 352 (Pubitemid 30131042)
53. Wang W, Schulze CJ, Suarez-Pinzon WL, Dyck JR, Sawicki G, Schulz R. Intracellular action of matrix metalloproteinase-2 accounts for acute myocardial ischemia and reperfusion injury. Circulation: 2002; 106 12 1543 1549
54. Novogrodsky A, Quittner S, Rubin AL, Stenzel KH. Transglutaminase activity in human lymphocytes: early activation by phytomitogens. Proc Natl Acad Sci U S A: 1978; 75 3 1157 1161 (Pubitemid 8305227)
55. Lai TS, Liu Y, Li W, Greenberg CS. Identification of two GTP-independent alternatively spliced forms of tissue transglutaminase in human leukocytes, vascular smooth muscle, and endothelial cells. FASEB J: 2007; 21 14 4131 4143 (Pubitemid 350232370)
56. James S, Flodin M, Johnston N, Lindahl B, Venge P. The antibody configurations of cardiac troponin I assays may determine their clinical performance. Clin Chem: 2006; 52 5 832 837 (Pubitemid 43673261)
57. Panteghini M. Selection of antibodies and epitopes for cardiac troponin immunoassays: should we revise our evidence-based beliefs? Clin Chem: 2005; 51 5 803 804 (Pubitemid 40577914)
58. Eriksson S, Pettersson K. Beliefs in cardiac troponin testing. Clin Chem: 2005; 51 9 1755 1756
59. Shi Q, Ling M, Zhang X., et al. Degradation of cardiac troponin I in serum complicates comparisons of cardiac troponin I assays. Clin Chem: 1999; 45 7 1018 1025 (Pubitemid 29340539)
60. Krudy GA, Kleerekoper Q, Guo XD, Howarth JW, Solaro RJ, Rosevear PR. NMR studies delineating spatial relationships within the cardiac troponin I-troponin C complex. J Biol Chem: 1994; 269 38 23731 23735 (Pubitemid 24293581)
61. Morjana N, Clark D, Tal R. Biochemical and immunological properties of human cardiac troponin I fragments. Biotechnol Appl Biochem: 2001; 33 Pt 2 107 115 (Pubitemid 32304288)
62. Lippi G, Avanzini P, Dipalo M, Aloe R, Cervellin G. Influence of hemolysis on troponin testing: studies on Beckman Coulter UniCel Dxl 800 Accu-TnI and overview of the literature. Clin Chem Lab Med: 2011;; In press
63. Hawkins RC. Hemolysis interference in the ortho-clinical diagnostics vitros ECi cTnI assay. Clin Chem: 2003; 49 7 1226, discussion 1227
64. Dasgupta A, Wells A, Biddle DA. Negative interference of bilirubin and hemoglobin in the MEIA troponin I assay but not in the MEIA CK-MB assay. J Clin Lab Anal: 2001; 15 2 76 80 (Pubitemid 32275230)
65. Plebani M, Lippi G. Hemolysis index: quality indicator or criterion for sample rejection? Clin Chem Lab Med: 2009; 47 8 899 902
66. Panteghini M, Bunk DM, Christenson RH., et al. IFCC Working Group on Standardization of Troponin I. Standardization of troponin I measurements: an update. Clin Chem Lab Med: 2008; 46 11 1501 1506